Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole in H. Pylori Infected Patients With GERD
NCT00574925Phase 4Completed
- Sponsor
- University of Zurich
- Start
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esomeprazole in gastroesophageal reflux disease (GERD) and Helicobacter pylori infection (3 arms), sponsored by University of Zurich. Primary endpoint: Time to relapse of GERD symptoms. Started Nov 2003; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)Helicobacter pylori infection
Beyond the preview
Go deeper on NCT00574925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00574925.